Plus Therapeutics (PSTV) Prepaid Assets (2010 - 2026)
Plus Therapeutics (PSTV) reported Prepaid Assets of $1.6 million for Q1 2026, up 56.24% year-over-year from $1.0 million in Q1 2025, and up 188.03% quarter-over-quarter from $543000.0 in Q4 2025.
Plus Therapeutics (PSTV) Prepaid Assets (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Prepaid Assets data on file, last reported at $1.6 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $1.6 million, up 56.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 56.24% YoY), and the FY2025 annual result was $543000.0, up 524.14% from the prior year.
- Prepaid Assets improved to $1.6 million in Q1 2026 per PSTV's latest filing, from $543000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.6 million in Q1 2026 and troughed at $87000.0 in Q4 2024.
- A 5-year average of $805058.8 and a median of $799000.0 in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets slumped 86.32% in 2024, then jumped 524.14% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $698000.0 in 2022, then declined by 8.88% to $636000.0 in 2023, then tumbled by 86.32% to $87000.0 in 2024, then jumped by 524.14% to $543000.0 in 2025, then jumped by 188.03% to $1.6 million in 2026.
- Business Quant data shows PSTV's Prepaid Assets at $1.6 million in Q1 2026, $543000.0 in Q4 2025, and $985000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 543,000.00 |
| Sep 30, 2025 | 985,000.00 |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 945,000.00 |
| Mar 31, 2024 | 989,000.00 |
| Dec 31, 2023 | 636,000.00 |
| Sep 30, 2023 | 487,000.00 |
| Jun 30, 2023 | 751,000.00 |
| Mar 31, 2023 | 906,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 540,000.00 |
| Jun 30, 2022 | 799,000.00 |
| Mar 31, 2022 | 865,000.00 |
| Dec 31, 2021 | 622,000.00 |
| Sep 30, 2021 | 817,000.00 |
| Jun 30, 2021 | 840,000.00 |